Bioxytran, Inc. (BIXT)
BIXT Stock Price Chart
Explore Bioxytran, Inc. interactive price chart. Choose custom timeframes to analyze BIXT price movements and trends.
BIXT Company Profile
Discover essential business fundamentals and corporate details for Bioxytran, Inc. (BIXT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Jan 2010
Employees
3.00
Website
https://www.bioxytraninc.comCEO
David Platt
Description
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.
BIXT Financial Timeline
Browse a chronological timeline of Bioxytran, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 11 Aug 2025
EPS came in at $0.00 .
Earnings released on 15 May 2025
EPS came in at -$0.02 .
Earnings released on 3 Apr 2025
EPS came in at -$0.01 .
Earnings released on 28 Oct 2024
EPS came in at -$0.00 .
Earnings released on 14 Aug 2024
EPS came in at -$0.00 .
Earnings released on 19 Apr 2024
EPS came in at -$0.00 , while revenue for the quarter reached $29.86K .
Earnings released on 22 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached -$118.24K .
Earnings released on 2 Nov 2023
EPS came in at -$0.01 , while revenue for the quarter reached $50.50K .
Earnings released on 31 Jul 2023
EPS came in at -$0.01 .
Earnings released on 12 May 2023
EPS came in at -$0.01 , while revenue for the quarter reached $67.74K .
Earnings released on 31 Mar 2023
EPS came in at -$0.01 .
Earnings released on 10 Nov 2022
EPS came in at -$0.00 .
Earnings released on 15 Aug 2022
EPS came in at -$0.01 .
Earnings released on 23 May 2022
EPS came in at -$0.01 .
Earnings released on 11 Apr 2022
EPS came in at -$0.01 .
Earnings released on 17 Nov 2021
EPS came in at -$0.00 .
Earnings released on 10 Aug 2021
EPS came in at -$0.01 .
Earnings released on 17 May 2021
EPS came in at -$0.02 .
Earnings released on 9 Apr 2021
EPS came in at -$0.01 .
Earnings released on 13 Nov 2020
EPS came in at -$0.00 .
BIXT Stock Performance
Access detailed BIXT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.